Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lori J. Ducharme is active.

Publication


Featured researches published by Lori J. Ducharme.


Work And Occupations | 2000

Unrewarding Work, Coworker Support, and Job Satisfaction: A Test of the Buffering Hypothesis

Lori J. Ducharme; Jack K. Martin

Beneficial effects of social support in the workplace have received only limited attention from sociologists. Workgroup interactions, especially social support received from coworkers, may significantly contribute to job satisfaction. This article assesses the effects of coworker support on job satisfaction, paying particular attention to the nature and influence of instrumental coworker support both relative to and in conjunction with affective coworker support. The authors expect that both affective and instrumental social support will exert significant and independent effects on these outcomes and that instrumental support will buffer the effects of nonrewarding work on job satisfaction. These hypotheses are tested in a series of ordinary least squares regression models. Data are drawn from a nationally representative sample of 2,505 full-time employees. Study findings are consistent with a main effects model of workplace social support. Suggestions for the absence of buffering effects, implications for industrial policy, and future research efforts are offered.


Journal of Occupational Health Psychology | 2009

Turnover intention and emotional exhaustion "at the top": Adapting the job demands-resources model to leaders of addiction treatment organizations

Hannah K. Knudsen; Lori J. Ducharme; Paul M. Roman

Compared with the large literature on subordinate employees, there are few studies of emotional exhaustion and turnover intention for organizational leaders. There is little research that has extended the job demands-resources (JD-R) model of emotional exhaustion to leaders. In this study, the authors adapted the JD-R framework to analyze data collected from a sample of 410 leaders of addiction treatment organizations. The authors considered whether two job demands (performance demands and centralization) and two job resources (innovation in decision making and long-range strategic planning) were associated with emotional exhaustion and turnover intention. The authors also examined whether emotional exhaustion fully or partially mediated the associations between the job-related measures and turnover intention. The results supported the partially mediated model. Both job demands were positively associated with emotional exhaustion, and the association for long-range strategic planning was negative. Emotional exhaustion was positively associated with turnover intention. Centralization and innovation in decision making were also directly associated with turnover intention. Future research should continue to examine this theoretical framework among leaders of other types of organizations using more refined measures of demands and resources.


Substance Abuse Treatment Prevention and Policy | 2008

State policy influence on the early diffusion of buprenorphine in community treatment programs.

Lori J. Ducharme; Amanda J. Abraham

BackgroundBuprenorphine was approved for use in the treatment of opioid dependence in 2002, but its diffusion into everyday clinical practice in community-based treatment programs has been slow. This study examines the net impact of efforts by state agencies, including provision of Medicaid coverage, on program-level adoption of buprenorphine as of 2006.MethodsInterviews were conducted with key informants in 49 of the 50 state agencies with oversight responsibility for addiction treatment services. Information from these interviews was integrated with organizational data from the 2006 National Survey of Substance Abuse Treatment Services. A multivariate logistic regression model was estimated to identify the effects of state efforts to promote the use of this medication, net of a host of organizational characteristics.ResultsThe availability of Medicaid coverage for buprenorphine was a significant predictor of its adoption by treatment organizations.ConclusionInclusion of buprenorphine on state Medicaid formularies appears to be a key element in ensuring that patients have access to this state-of-the-art treatment option. Other potential barriers to the diffusion of buprenorphine require identification, and the value of additional state-level policies to promote its use should be evaluated.


Journal of Behavioral Health Services & Research | 2007

Service delivery in substance abuse treatment: reexamining "comprehensive" care.

Lori J. Ducharme; Heather L. Mello; Paul M. Roman; Hannah K. Knudsen; J. Aaron Johnson

Substance abuse treatment clients present with an array of service needs in various life domains. Ideal models of addiction treatment incorporate provision or linkages to services to meet clients’ multiple needs; in turn, these wraparound and supportive services are associated with improvements in client retention and treatment outcomes. Using data from large samples of specialty addiction treatment providers in the public and private sectors, this article examines the extent and organizational correlates of the comprehensiveness of service delivery. Multivariate models indicate that private sector treatment facilities offer more “core” medical and treatment services, whereas public sector programs offer more wraparound and supportive services. However, both sectors fall short of the ideal model of service comprehensiveness in terms of absolute number of services offered. These findings raise concerns regarding the quality and availability of needed services for treatment of addiction.


Journal of Clinical Psychopharmacology | 2006

Trends in the adoption of medications for alcohol dependence

Lori J. Ducharme; Hannah K. Knudsen; Paul M. Roman

Increasing attention is being paid to the development and dissemination of effective pharmacotherapies for the treatment of alcohol and other drug dependence. However, numerous structural and philosophical barriers impede the widespread adoption of these treatment approaches in everyday clinical practice. Research is needed to understand and overcome this gap. Drawing upon data collected from 2 large samples of substance abuse treatment providers at multiple time points, this article examines the prevalence and correlates of the adoption of the currently available pharmacotherapies for alcohol dependence: disulfiram, oral naltrexone, and acamprosate. These data suggest that the proportion of treatment programs using pharmacotherapies for alcohol dependence has been declining over time. In addition, the proportion of patients to whom these medications are prescribed is notably low. The adoption of disulfiram and naltrexone is significantly more likely in programs that are accredited, employ at least 1 physician, offer integrated care for patients with co-occurring psychiatric conditions, derive proportionately more revenue from commercial insurance payers, and have fewer linkages with the criminal justice system. Preliminary data suggest that the early adoption of acamprosate is following a similar pattern. Recommendations for addressing challenges to the diffusion of pharmacotherapies for alcohol dependence are presented.


Journal of Substance Abuse Treatment | 2009

Opioid treatment programs in the Clinical Trials Network: Representativeness and buprenorphine adoption

Lori J. Ducharme; Paul M. Roman

As the Clinical Trials Network (CTN) begins to focus efforts on disseminating the results of its research studies to the addiction treatment field, it is important to begin to assess the capacity of programs outside the CTN to integrate with fidelity these endorsed treatment practices. To date, no data exist to assess the representativeness of opioid treatment programs (OTPs) participating in the CTN, nor potential barriers to the effective diffusion of practices aimed at the treatment of opioid-dependent patients, including buprenorphine. Using data obtained from OTPs within the CTN (n = 49) and a sample drawn from the population of U.S. OTPs (n = 50), this study compares the two groups on their organizational, clinical, and client characteristics, as well as their adoption of buprenorphine. The study finds that the populations differ significantly on numerous variables but that structural characteristics appear more predictive of buprenorphine adoption than either staff or caseload differences. Implications for studying the diffusion and implementation of evidence-based research findings are discussed.


Community Mental Health Journal | 2006

Availability of Integrated Care for Co-occurring Substance Abuse and Psychiatric Conditions

Lori J. Ducharme; Hannah K. Knudsen; Paul M. Roman

The co-occurrence of psychiatric conditions and substance abuse presents significant challenges for behavioral healthcare providers. The need for integrated care has received substantial recent attention from clinical, research, and funding entities. However, the availability of integrated care has been low, carrying potential adverse implications for quality of care and treatment outcomes. This article describes the prevalence and key correlates of the availability of integrated care for co-occurring conditions within public and private-sector addiction treatment programs. Several organizational attributes, caseload characteristics, and service provision patterns were associated with the availability of integrated care.


Journal of Drug Issues | 2005

Organizational Predictors of Pharmacological Innovation Adoption: The Case of Disulfiram

Hannah K. Knudsen; Paul M. Roman; Lori J. Ducharme; J. Aaron Johnson

The research-to-practice gap in substance abuse treatment, particularly with regard to pharmacological innovations, necessitates the consideration of organizational characteristics that facilitate the adoption of innovations. Using data from a nationally representative sample of 394 privately funded substance abuse treatment centers, this study examines variation in the adoption of disulfiram in terms of organizational structure, workforce professionalism, and treatment philosophy. Logistic regression results indicated that hospital-based centers were significantly more likely to use disulfiram than freestanding treatment programs. In addition, the percentage of counselors with masters degrees and the percentage of certified/licensed counselors were positively associated with the likelihood of disulfiram utilization. Treatment centers that emphasized confrontational group therapy and spirituality were less likely to use disulfiram, while the adoption of disulfiram was more likely in centers that emphasized a medical model of addiction.


Annual Review of Public Health | 2017

An Overview of Research and Evaluation Designs for Dissemination and Implementation

C. Hendricks Brown; Geoffrey M. Curran; Lawrence A. Palinkas; Gregory A. Aarons; Kenneth B. Wells; Loretta Jones; Linda M. Collins; Naihua Duan; Brian S. Mittman; Andrea S. Wallace; Rachel G. Tabak; Lori J. Ducharme; David A. Chambers; Gila Neta; Tisha R. A. Wiley; John Landsverk; Ken Cheung; Gracelyn Cruden

The wide variety of dissemination and implementation designs now being used to evaluate and improve health systems and outcomes warrants review of the scope, features, and limitations of these designs. This article is one product of a design workgroup that was formed in 2013 by the National Institutes of Health to address dissemination and implementation research, and whose members represented diverse methodologic backgrounds, content focus areas, and health sectors. These experts integrated their collective knowledge on dissemination and implementation designs with searches of published evaluations strategies. This article emphasizes randomized and nonrandomized designs for the traditional translational research continuum or pipeline, which builds on existing efficacy and effectiveness trials to examine how one or more evidence-based clinical/prevention interventions are adopted, scaled up, and sustained in community or service delivery systems. We also mention other designs, including hybrid designs that combine effectiveness and implementation research, quality improvement designs for local knowledge, and designs that use simulation modeling.


Journal of Psychoactive Drugs | 2009

Modified therapeutic communities and adherence to traditional elements.

Meredith Huey Dye; Lori J. Ducharme; J. Aaron Johnson; Hannah K. Knudsen; Paul M. Roman

Abstract Traditional therapeutic communities (TCs) are characterized by confrontational group therapy, treatment phases, a tenure-based resident hierarchy, and long-term residential care. Many TCs have modified the structure and intensity of the traditional model, tailored services for specific client populations, and hired more professionally trained staff. This study examines the extent to which modified TCs are able to retain the underlying core technology of the TC. Using data from a nationally representative sample of 380 self-identified TCs, six traditional TC elements are identified. Results from a structural equation model indicate that offering services for specific populations and professionalization of staff has limited impact on the six TC elements. Modifications to structure and intensity of TC programming evidenced the strongest effect. Specifically, outpatient-only TCs showed significantly lower adherence to five of the six elements. Short-term residential programs showed a similar negative trend. Findings suggest selected modifications are possible without significantly impacting the TC models core technology.

Collaboration


Dive into the Lori J. Ducharme's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jennifer Pankow

Texas Christian University

View shared research outputs
Top Co-Authors

Avatar

Kevin Knight

Texas Christian University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sami Abdel-Salam

West Chester University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Tisha R. A. Wiley

National Institute on Drug Abuse

View shared research outputs
Researchain Logo
Decentralizing Knowledge